marginally significantP=0.065
Regarding DFS, only the administration of regimens involving CD-DST-selected drugs was found to be a prognostic factor (P=0.037), although EGFR status was demonstrated to be a marginally significant factor (P=0.065).
Regarding DFS, only the administration of regimens involving CD-DST-selected drugs was found to be a prognostic factor (P=0.037), although EGFR status was demonstrated to be a marginally significant factor (P=0.065).